口服固体製剂市场规模、份额及成长分析（按剂型、药物释放机制、通路、应用、製造路线、形式及地区）－产业预测，2025-2032

2023 年口服固体製剂市场规模价值 6,454.2 亿美元，预计将从 2024 年的 6,867.3 亿美元成长到 2032 年的 11,280.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.4%。

由于口服药物需求的不断增加和配方技术的进步，全球口服固体製剂市场预计将经历强劲增长。需要长期药物治疗的老龄化人口进一步推动了市场向创新药物传递方法的发展，以提高患者的依从性和治疗效果。日益严格的政府监管迫使製药公司注重品质和安全，增加了对研发的投资。此外，製药公司和受託製造厂商之间的策略联盟正在扩大产品系列併加强市场动态。因此，口服固体製剂市场正在不断发展，以满足医疗保健产业的动态需求。

目录

介绍

• 调查目的
• 定义
• 市场覆盖

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概览展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场动态
  • 驱动程式
  • 机会
  • 限制因素
  • 任务
• 波特的分析

关键市场考察

• 技术分析
• 价值链分析
• 市场生态系统
• 监管格局
• 创新矩阵
• 重大投资分析
• 关键成功因素
• 竞争程度

口服固体製剂市场（依产品类型）

• 市场概览
• 药片
  • 常规/即时释放
  • 修復版本
  • 咀嚼锭
  • 发泡
• 胶囊
  • 硬明胶胶囊
  • 软胶囊
• 粉末/颗粒
• 锭剂和软糖
• 软糖

口服固体製剂市场（依机制区分）

• 市场概览
• 控释
• 即时发布
• 延迟释放

口服固体製剂市场（依最终用户划分）

• 市场概览
• 大型企业
• 中小企业
• 其他（Start-Ups和学名药公司）

口服固体製剂市场规模（按地区）

• 市场概览
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲（MEA）
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争格局

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2024年）

主要企业简介

• Pfizer Inc.（United States）
• Novartis AG（Switzerland）
• GlaxoSmithKline plc（United Kingdom）
• Sanofi SA（France）
• Merck & Co., Inc.（United States）

Oral Solid Dosage Pharmaceutical Formulation Market size was valued at USD 645.42 billion in 2023 and is poised to grow from USD 686.73 billion in 2024 to USD 1128.02 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).

The Global Oral Solid Dosage Pharmaceutical Formulation Market is poised for robust growth, driven by a rising demand for oral medications and advancements in drug formulation technologies. With an aging population that necessitates prolonged pharmaceutical treatment, the market is further supported by innovative drug delivery methods that enhance patient compliance and therapeutic effectiveness. Stricter regulations by authorities are compelling pharmaceutical companies to focus on quality and safety, leading to increased investments in research and development. Moreover, strategic collaborations between pharmaceutical firms and contract manufacturing organizations are expanding product portfolios and enhancing market dynamics. As a result, the oral solid dosage market is set for sustained evolution, aligning with the dynamic needs of the healthcare industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Oral Solid Dosage Pharmaceutical Formulation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Oral Solid Dosage Pharmaceutical Formulation Market Segments Analysis

Global Oral Solid Dosage Pharmaceutical Formulation Market is segmented by Dosage Form, Drug Release Mechanism, Distribution Channel, Application, Manufacturing Route, Form, Dosage Strength, Route of Administration, Target Patient Population and region. Based on Dosage Form, the market is segmented into Tablets, Capsules, Powders and Granules, Lozenges and Pastilles and Gummies. Based on Drug Release Mechanism, the market is segmented into Immediate Release, Delayed Release and Controlled Release. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies and Hypermarkets/Supermarkets. Based on Application, the market is segmented into Cardiovascular, Anti-infectives, Central Nervous System, Pain Management, Anti-inflammatory and Others. Based on Manufacturing Route, the market is segmented into Direct Compression, Granulation, Extrusion-Spheronization, Coating and Film Coating. Based on Form, the market is segmented into Immediate Release, Sustained Release, Extended Release, Controlled Release and Enteric Coated. Based on Dosage Strength, the market is segmented into Low, Medium, High, Ultra-High and Specialty. Based on Route of Administration, the market is segmented into Oral, Sublingual, Buccal and Nasal. Based on Target Patient Population, the market is segmented into Adults, Geriatrics, Pediatrics, Neonates and Pregnant Women. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Oral Solid Dosage Pharmaceutical Formulation Market

Advancements in technology, such as 3-D printing, nanotechnology, and advanced drug delivery systems, are significantly improving the performance and efficacy of oral solid dosage pharmaceuticals. These innovations not only enhance patient adherence to medication regimens but also empower pharmaceutical companies to create novel formulations, thereby driving market growth. By harnessing these cutting-edge technologies, the industry is able to optimize drug effectiveness and tailor solutions to meet diverse patient needs, ultimately contributing to a more robust and dynamic Oral Solid Dosage Pharmaceutical Formulation market. As a result, these developments play a pivotal role in shaping the future of pharmaceutical manufacturing and patient care.

Restraints in the Oral Solid Dosage Pharmaceutical Formulation Market

The Oral Solid Dosage Pharmaceutical Formulation market faces significant constraints due to the intense scrutiny imposed by regulatory agencies globally, which aim to ensure the safety and effectiveness of drugs. The lengthy and complex approval processes associated with these regulations can lead to delays in product launches, increased development costs, and hinder market entry for new competitors. As companies strive to comply with these stringent requirements, navigating the regulatory landscape becomes a considerable challenge that can impact innovation and overall market growth in this sector. The need to meet such high standards remains a central obstacle for many organizations in the industry.

Market Trends of the Oral Solid Dosage Pharmaceutical Formulation Market

The Oral Solid Dosage Pharmaceutical Formulation market is experiencing a significant shift towards personalized medicine, driven by advancements in genetic profiling and biomarker identification. This trend enables pharmaceutical companies to create tailored formulations that cater to the unique needs of individual patients, significantly enhancing treatment efficacy and promoting adherence. As healthcare increasingly emphasizes patient-centric approaches, the demand for these customized oral solid dosage forms is projected to surge, cultivating niche markets within the industry. Companies focusing on precision formulations are likely to gain a competitive edge, fueling innovation and growth in this evolving landscape.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Oral Solid Dosage Pharmaceutical Market by Product Type

• Market Overview
• Tablets
  • Conventional/Immediate Release
  • Modified Release
  • Chewable Tablets
  • Effervescent Tablets
• Capsules
  • Hard Gelatin Capsules
  • Soft Gelatin Capsules
• Powders & Granules
• Lozenges & Pastilles
• Gummies

Oral Solid Dosage Pharmaceutical Market by Mechanism

• Market Overview
• Controlled-release
• Immediate-release
• Delayed-release

Oral Solid Dosage Pharmaceutical Market by End User

• Market Overview
• Large-size Companies
• Medium- & Small-size Companies
• Others (Startups & Generic Pharmaceutical Companies)

Oral Solid Dosage Pharmaceutical Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2024

Key Company Profiles

• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments